2022
DOI: 10.1016/s0090-8258(22)01352-x
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacologic inhibition of beta-adrenergic receptors decreases PD-L1 mediated immunosuppression and improves anti-tumor immune signature in ovarian cancer (126)

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles